중재적 종양학 시장 규모, 점유율, 성장 분석 : 제품 유형별, 시술 유형별, 암 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Interventional Oncology Market size was valued at USD 2.31 Billion in 2024 and is poised to grow from USD 2.47 Billion in 2025 to USD 4.18 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

Interventional oncology represents a rapidly growing segment of cancer care that utilizes minimally invasive techniques combined with advanced imaging technologies such as CT, ultrasound, MRI, and X-rays. These procedures are designed to precisely target and eliminate cancer cells, minimizing the need for invasive surgeries. Utilizing specialized instruments like intravascular catheters, biopsy needles, and ablation electrodes ensures effective targeting of tumors, even those in remote areas of the body. The integration of interventional oncology with traditional oncology approaches-such as radiation therapy, surgery, and medical oncology-enhances the overall patient experience by providing focused treatments that relieve symptoms and improve outcomes. This approach is applicable to various cancers, including liver, kidney, lung, and breast cancers, emphasizing its pivotal role in contemporary cancer management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Interventional Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Interventional Oncology Market Segments Analysis

Global Interventional Oncology Market is segmented on the basis of product, cancer type, procedure, end user, and region. By product, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. By Cancer Type, the market is segmented into Liver Cancer, Kidney Cancer, Breast Cancer, Lung Cancer, Bone Cancer, Prostate Cancer, and Other Cancers. By procedure, the market is segmented into Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (TARE/SIRT), Transcatheter Arterial Chemoembolization (TACE), Thermal Tumor Ablation, and Transcatheter Arterial Embolization/Bland Embolization (TAE). By end-user, the market is segmented into hospitals, ambulatory surgery centers, and research & academic institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Interventional Oncology Market

The rising incidence of cancer worldwide significantly fuels the interventional oncology market. As the global population ages and lifestyle-related risk factors contribute to higher cancer rates, the need for effective treatment solutions continues to surge. This escalating demand encourages healthcare professionals to embrace advanced interventional techniques that improve patient outcomes and boost survival rates. The focus on innovative treatment methods reflects a commitment to addressing the challenges posed by cancer, ultimately driving the growth of the interventional oncology sector and fostering advancements in patient care and recovery.

Restraints in the Global Interventional Oncology Market

A significant constraint on the growth of the Global Interventional Oncology market is the limited awareness and training among healthcare professionals regarding interventional oncology techniques. Many practitioners lack familiarity with the latest innovations and procedures, which contributes to their underutilization. Furthermore, the necessity for specialized training can impede the swift adoption of new technologies across various healthcare environments, posing a challenge to effectively integrating these advanced practices into regular patient care. This lack of knowledge and training ultimately affects the overall development and expansion of interventional oncology within the global market.

Market Trends of the Global Interventional Oncology Market

The Global Interventional Oncology market is witnessing a pronounced shift towards minimally invasive techniques, reflecting a growing preference among patients and healthcare providers for treatments that minimize recovery times and complications. This trend is propelled by advancements in technology, fostering the development of innovative tools and methodologies that enhance precision and treatment efficacy. As awareness of the benefits of these approaches spreads, there is an increasing emphasis on targeted therapies that not only improve patient outcomes but also optimize healthcare resources. This evolution in interventional oncology signifies a transformative period characterized by enhanced patient care and satisfaction.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Interventional Oncology Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Ablation Devices
  • Radiofrequency (RF) Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Irreversible Electroporation Devices
  • High-Intensity Focused Ultrasound (HIFU) Systems
• Embolization Devices
  • Radioembolization Devices (Y-90 Microspheres)
  • Transarterial Chemoembolization (TACE) Agents
  • Drug-Eluting Beads (DEBs)
  • Non-drug-eluting Beads
• Support Devices
  • Microcatheters
  • Guidewires
  • Needles (biopsy, ablation)
  • Introducers and Sheaths
  • Imaging Contrast Agents
• Others
  • Robotic Assistance Systems
  • Software Platforms for Planning and Navigation

Global Interventional Oncology Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Thermal Ablation
• Non-thermal Ablation
• Embolization Procedures
• Vertebroplasty & Cementoplasty
• Biopsy and Tumor Marking Procedures

Global Interventional Oncology Market Size by Cancer Type & CAGR (2026-2033)

• Market Overview
• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Bone Metastases
• Breast Cancer
• Prostate Cancer
• Pancreatic Cancer
• Colorectal Cancer
• Others

Global Interventional Oncology Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Cancer Research Centers
• Interventional Radiology Clinics

Global Interventional Oncology Market Size & CAGR (2026-2033)

• North America (Product Type, Procedure Type, Cancer Type, End User)
  • US
  • Canada
• Europe (Product Type, Procedure Type, Cancer Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Procedure Type, Cancer Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Procedure Type, Cancer Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Procedure Type, Cancer Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALPINION MEDICAL SYSTEMS - South Korea
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ATRICURE, INC. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EndoShape, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABK Biomedical Inc. - Canada
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sirtex Medical Limited - Australia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTG International Ltd. - UK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare - Netherlands
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations